Sir David Weatherall reflects on genetics and personalized medicine. Interviewed by Ulrike Knies-Bamforth.
Weatherall
David
D
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003906:Developing Countries; D016503:Drug Delivery Systems; D004345:Drug Industry; D004358:Drug Therapy / Q000639:trends; D006801:Humans; D010548:Personal Health Services / Q000639:trends*; D010597:Pharmacogenetics; D013789:Thalassemia / Q000235:genetics; D006113:United Kingdom; D014481:United States; D014944:World Health Organization
D000970:Antineoplastic Agents